A severe combined immunodeficient mouse model for the in vivo study of acoustic schwannoma

Kumazawa, Hirobumi; Kyoumoto, Ryouichi; Matsumoto, Ayumi; Baba, Kazuyasu; Tomoda, Kouichi; Yamashita, Toshio; Tsubura, Airo

doi:10.1016/s0196-0709(96)90086-1

American Journal of Otolaryngology

1996

DOI: 10.1016/s0196-0709(96)90086-1

|View full text |Cite

A severe combined immunodeficient mouse model for the in vivo study of acoustic schwannoma

Hirobumi Kumazawa¹,

Ryouichi Kyoumoto²,

Ayumi Matsumoto³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2009

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Xenografted tumors have shown some success in the ability to grow human schwannoma tumors, but the growth rates are not consistent, and the tumor location of most models (flank, thigh) do not mimic the human disease (intracranial tumors) (3–6). Orthotopic xeno-transplants have the advantage that they derive from human tumors; therefore, they most closely resemble the pathologic process, and the tumor or cells are implanted in the area of interest such as the cerebrospinal fluid space.…”

mentioning

confidence: 99%

Bioluminescent Imaging of Intracranial Vestibular Schwannoma Xenografts in NOD/SCID Mice

Neff¹,

Voss²,

Allen³

et al. 2009

Otology &Amp; Neurotology

View full text Add to dashboard Cite

Hypothesis Intracranial vestibular schwannoma xenografts can be successfully established and followed with bioluminescent imaging (BLI). Background Transgenic and xenograft mouse models of vestibular schwannomas have been previously reported in the literature. However, none of these models replicate the intracranial location of these tumors to reflect the human disease. Additionally, traditional imaging methods (magnetic resonance imaging, computed tomography) for following tumor engraftment and growth are expensive and time consuming. BLI has been successfully used to longitudinally follow tumor treatment responses in a noninvasive manner. BLI’s lower cost and labor demands make this a more feasible approach for tumor monitoring in studies involving large numbers of mice. Methods Patient excised vestibular schwannomas were cultured and transduced with firefly luciferase expressing lentivirus. One million cells were stereotactically injected into the right caudate nucleus of 21 nonobese diabetic/severe combined immunodeficient mice. Schwannoma engraftment and growth was prospectively followed for 30 weeks after injection with BLI. After animal sacrifice, the presence of human tumor cells was confirmed with fluorescent in situ hybridization. Results Eight (38%) of 21 mice successfully engrafted the schwannoma cells. All of these mice were generated from 4 (67%) of the 6 patient excised tumors. These 8 mice could be differentiated from the nonengrafted mice at 21 weeks. The engrafted group emitted BLI of greater than 100,000 photons/s (range, 142,478–3,106,300 photons/s; average, 618,740 photons/s), whereas the nonengrafted group were all under 100,000 photons/s (range, 0–76,010 photons/s; average, 10,737 photons/s) (p < 0.001). Fluorescent in situ hybridization analysis confirmed the presence of viable human schwannoma cells in much greater numbers in those mice with stable or growing tumors compared with those whose tumors regressed. Conclusion We have successfully established an intracranial schwannoma xenograft model that can be followed with noninvasive BLI. We hope to use this model for in vivo testing of schwannoma tumor therapies.

show abstract

mentioning

confidence: 99%

Bioluminescent Imaging of Intracranial Vestibular Schwannoma Xenografts in NOD/SCID Mice

Neff¹,

Voss²,

Allen³

et al. 2009

Otology &Amp; Neurotology

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

A severe combined immunodeficient mouse model for the in vivo study of acoustic schwannoma

Cited by 1 publication

References 16 publications

Bioluminescent Imaging of Intracranial Vestibular Schwannoma Xenografts in NOD/SCID Mice

Bioluminescent Imaging of Intracranial Vestibular Schwannoma Xenografts in NOD/SCID Mice

Contact Info

Product

Resources

About